Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

129.99 -5.43 (-4.01%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,758,399
Open 134.94
Bid (Size) 129.87 (3)
Ask (Size) 130.25 (1)
Prev. Close 135.42
Today's Range 126.83 - 134.97
52wk Range 77.95 - 148.15
Shares Outstanding N/A
Dividend Yield 1.36%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry. 
Via Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), often referred to as the market’s fear gauge, spiked over 10%, reaching levels... 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
+27.30%
+27.30%
1 Month
-7.68%
-7.68%
3 Month
+5.90%
+5.90%
6 Month
+20.86%
+20.86%
1 Year
+62.25%
+62.25%

More News

Read More
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
Via Benzinga
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Forget Boring Diversification! 3 Wild-Card Stocks to Spice Up Your Portfolio
Via InvestorPlace
Novo Nordisk Faces Setback in Netherlands Over Wegovy Insurance Coverage
Via Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
Via The Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
Via Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
Via Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
Via Investor's Business Daily
3 Hot Growth Stocks That Will Make You Forget About AMD
Via InvestorPlace
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
Via Benzinga
3 Dow Jones Stocks to Buy at 52-Week Lows in July
Via InvestorPlace
Topics Stocks
Exposures US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
Via Benzinga
7 Top-Quality Stocks to Buy Now: July 2024
Via InvestorPlace
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Via The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy Now
Via The Motley Fool
Is Eli Lilly a Good Dividend Stock to Buy Now?
Via The Motley Fool
This 1 Piece of Bad News for Novo Nordisk Is Good News for Eli Lilly Stock
Via The Motley Fool
Here's 80 Billion More Reasons to Buy Novo Nordisk Stock
Via The Motley Fool
The 7 Most Important Stocks to Watch as Q2 Earnings Season Kicks Off
Via InvestorPlace
Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
Via The Motley Fool
The Weight Loss Market Can Surge To $400B By 2032, And These Stocks Will Rule It
Via Talk Markets
Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.